Blood test for Alzheimer's marker could speed up memory care decisions
NCT ID NCT07140744
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether a blood test for a protein called P-tau217 can help doctors make faster and better decisions for people with memory concerns. Researchers will compare what happens when doctors have the test results versus standard care. The study involves 7,000 participants and is currently recruiting.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- P-tau217 blood biomarker test
- What this could lead to
- If successful, this blood test could help doctors detect Alzheimer's-related changes earlier and guide treatment decisions for people with memory complaints.
- What could go wrong
- This is a diagnostic study, not a treatment trial. The test may not change patient outcomes, and results could be uncertain or lead to unnecessary worry.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBJECTIVE COGNITIVE IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
SiteRx Virtual Site
RECRUITINGNew York, New York, 10013, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Faith and fitness: can a healthy lifestyle ward off dementia?
- Brain scans may reveal Alzheimer's years before symptoms
- Light on the brain: could a headset improve memory and mood?
- AI and a simple blood test could spot Alzheimer's years early
- Massive canadian study tracks 1,500 brains to unlock dementia secrets
- Online brain health course could slash dementia risk